Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas.
作者： Roger Kuhn , Arndt Hribaschek , Katrin Eichelmann , Stephan Rudolph , Joerg Fahlke
关键词:
摘要: Purpose. The prognosis of patients withbiliary tree carcinomas is very poor. Thediagnosis often occurs at an advancedstage, when curative resection notpossible. We combined gemcitabine anddocetaxel to optimize the palliativetherapy for with gallbladder,biliary, and cholangio-carcinomas on anoutpatient basis.
springer.com
sci-hub.se 参考文章(18)
Keating M, Cohen J, Dimitt B, Reilly N, Miller R, Friedland D, Gluckman R, Voloshin M, Lembersky B, Zidar B, A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. Seminars in Oncology. ,vol. 26, pp. 19- 23 ,(1999)
Leslie H. Blumgart, Steven C. Stain, Surgical treatment of cholangiocarcinoma Cancer Treatment and Research. ,vol. 69, pp. 75- 96 ,(1994) , 10.1007/978-1-4615-2604-9_9
D V Jones, R Lozano, A Hoque, A Markowitz, Y Z Patt, Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. Journal of Clinical Oncology. ,vol. 14, pp. 2306- 2310 ,(1996) , 10.1200/JCO.1996.14.8.2306
M. Ducreux, P. Rougier, A. Fandi, M.-C. Clavero-Fabri, A.-L. Villing, F. Fassone, L. Fandi, J. Zarba, J.-P. Armand, Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin Annals of Oncology. ,vol. 9, pp. 653- 656 ,(1998) , 10.1023/A:1008241008379
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff, R Nelson, F A Dorr, C D Stephens, D D Von Hoff, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology. ,vol. 15, pp. 2403- 2413 ,(1997) , 10.1200/JCO.1997.15.6.2403
Henry A. Pitt, Charles J. Yeo, William C. Dooley, John L. Cameron, Malignancies of the biliary tree Current Problems in Surgery. ,vol. 32, pp. 1- 90 ,(1995) , 10.1016/S0011-3840(05)80011-5
W Scheithauer, G V Kornek, M Raderer, M Hejna, J Valencak, J Miholic, E Kovats, F Lang, J Funovics, E Bareck, D Depisch, Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. British Journal of Cancer. ,vol. 80, pp. 1797- 1802 ,(1999) , 10.1038/SJ.BJC.6690600
M Hejna, M Pruckmayer, M Raderer, The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature European Journal of Cancer. ,vol. 34, pp. 977- 986 ,(1998) , 10.1016/S0959-8049(97)10166-6
Vittorio Gebbia, Evaristo Majello, Antonio Testa, Giuseppe Pezzella, Serravezza Giuseppe, Francesco Giotta, Fernando Riccardi, Santo Fortunato, Giuseppe Colucci, Nicolò Gebbia, , Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule: Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.) Cancer. ,vol. 78, pp. 1300- 1307 ,(1996) , 10.1002/(SICI)1097-0142(19960915)78:6<1300::AID-CNCR19>3.0.CO;2-4
Margaret Barton-Burke, Gemcitabine: a pharmacologic and clinical overview. Cancer Nursing. ,vol. 22, pp. 176- 183 ,(1999) , 10.1097/00002820-199904000-00011